Brief: Cereno Scientific Obtains First Patent In India For Drug Candidate CS1 Through Its Third Patent Family
Nov 28 (Reuters) - Cereno Scientific AB CRNOSb.ST :
* OBTAINS FIRST PATENT IN INDIA FOR DRUG CANDIDATE CS1
THROUGH ITS
THIRD PATENT FAMILY
* PATENT WILL BE VALID THROUGH 2037
* THIS IS FIRST ISSUED PATENT IN INDIA FOR OUR CS1 PATENT
PORTFOLIO
Source text for Eikon: ID:nWkr4yLFvy
Further company coverage: CRNOSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global